Padmanee Sharma, M.D., Ph.D., associate vice president of Immunobiology, professor of Genitourinary Medical Oncology and Immunology, and director of scientific
/PRNewswire/ Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and.
Closed merger with Sesen Bio and commenced trading on Nasdaq under ticker symbol CARM
Cash position as of the closing of the merger with Sesen Bio provides anticipated operating runway through. | April 4, 2023